Eupraxia Pharmaceuticals Inc. (EPRX.TO) - Quarterly Balance Statement

Home
EPRX.TO
Financials

3.8 (CAD) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2019 Q4
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	31.905	48.592	19.342	33.21	19.096	18.848	24.736	11.804	17.392	16.881	20.892	33.667	36.076	31.116	0.15	0.429	1.156
Short Term Investments Numbers are in millions	0	0	0	0	0	0	0	18.173	18.063	9.023	9.009	0	0	0	0	0	0
Cash and Short Term Investments Numbers are in millions	31.905	48.592	19.342	33.21	19.096	18.848	24.736	29.977	35.455	25.904	29.901	33.667	36.076	31.116	0.15	0.429	1.156
Net Receivables Numbers are in millions	0.212	0.226	0.191	0.092	0.068	0.118	0.122	0.391	0.377	0.437	0.43	0.102	0.04	0.479	0.621	0.02	1.348
Inventory Numbers are in millions	0	0	-0.341	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	1.442	0.191	0.611	0.471	0.57	0.25	0.32	0.417	0.563	0.301	0.271	0.468	0.746	0.666	0	0	0
Total Current Assets Numbers are in millions	33.559	49.009	19.803	33.773	19.735	19.217	25.177	30.785	36.395	26.642	30.602	34.237	36.862	32.262	1.138	0.583	2.639
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	0.61	0.561	0.456	0.574	0.611	0.658	0.695	0.665	0.665	0.556	0.589	0.612	0.28	0.299	0.315	0.338	0.646
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.006	0.008	0.007	0.004	0.006	0.003	0.003	0.001	0.001	0.001	0.031	0.06	0	0	0	0	0
Total Non-Current Assets Numbers are in millions	0.616	0.569	0.463	0.578	0.617	0.66	0.699	0.666	0.665	0.558	0.62	0.673	0.28	0.299	0.315	0.338	0.646
Total Assets Numbers are in millions	34.175	49.578	20.266	34.351	20.351	19.877	25.876	31.451	37.06	27.199	31.222	34.91	37.142	32.56	1.454	0.921	3.285
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Term Debt Numbers are in millions	6.329	12.934	10.452	15.403	11.075	0.179	0.176	0.173	0.163	0.157	0.155	0.152	0.056	6.172	12.57	12.426	11.686
Tax Payables Numbers are in millions	0	0.056	0.036	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities Numbers are in millions	9.548	12.141	8.922	3.874	3.526	1.999	3.966	2.08	3.428	1.105	2.113	2.693	0.76	1.486	9.972	9.678	8.981
Total Current Liabilities Numbers are in millions	15.877	25.075	19.374	19.277	14.6	2.179	4.142	2.253	3.592	1.262	2.268	2.845	0.816	7.658	22.542	22.104	20.667
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0.035	0	0	0.012	0.059	10.589	10.37	10.117	9.859	9.617	9.401	9.228	8.784	0.184	0.199	0.212	0.251
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0.013	0	0	0	0	0.05	0	0	0	0	0	0	0	0	0.376	0.438	0.498
Total Non-Current Liabilities Numbers are in millions	0.048	0	0	0.012	0.059	10.639	10.37	10.117	9.859	9.617	9.401	9.228	8.784	0.184	0.575	0.65	0.749
Total Liabilities Numbers are in millions	15.925	25.075	19.374	19.289	14.66	12.818	14.512	12.37	13.451	10.88	11.669	12.074	9.601	7.842	23.117	22.754	21.416
Equity:
Preferred Stock Numbers are in millions	0	0	2.707	0	0	0	2.786	0	0	0	0	0	0	0	0	0	0
Common Stock Numbers are in millions	159.164	157.408	92.914	118.053	99.369	92.691	92.337	91.867	91.867	80.713	80.713	80.757	80.757	74.155	23.798	23.548	23.548
Retained Earnings Numbers are in millions	-160.852	-150.947	-108.208	-122.699	-110.233	-102.406	-97.446	-88.623	-83.968	-77.878	-74.187	-70.469	-65.494	-60.057	-51.197	-51.059	-47.2
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-3.994	-3.706	-2.707	0	0	-0	-2.786	0	0	0	0	0	0	0	0	0	0
Other Total Stockholders Equity Numbers are in millions	25.977	23.695	17.51	21.689	18.303	18.348	17.964	17.068	16.803	14.387	13.86	13.322	12.893	11.077	6.19	6.13	5.961
Total Shareholders Equity Numbers are in millions	20.295	26.449	2.216	17.044	7.439	8.633	12.855	20.312	24.702	17.222	20.387	23.611	28.155	25.174	-21.21	-21.381	-17.69
Total Equity Numbers are in millions	18.25	24.503	0.892	15.062	5.692	7.059	11.364	19.081	23.61	16.32	19.553	22.836	27.541	24.718	-21.664	-21.833	-18.131
Total Liabilities & Shareholders Equity Numbers are in millions	34.175	49.578	20.266	34.351	20.351	19.877	25.876	31.451	37.06	27.199	31.222	34.91	37.142	32.56	1.454	0.921	3.285

Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO Add to watchlist

TSX:EPRX.TO